Research Analysts’ price target changes for Monday, April 6th:
Alaris Equity Partners Income Trust (AD.UN) (TSE:AD.UN) had its target price increased by Acumen Capital from C$26.00 to C$26.50. They currently have a buy rating on the stock.
Agios Pharmaceuticals (NASDAQ:AGIO) had its target price boosted by JPMorgan Chase & Co. from $31.00 to $36.00. They currently have a neutral rating on the stock.
Advanced Micro Devices (NASDAQ:AMD) had its target price trimmed by Citigroup Inc. from $260.00 to $248.00. They currently have a neutral rating on the stock.
Acuity (NYSE:AYI) had its target price trimmed by The Goldman Sachs Group, Inc. from $342.00 to $295.00. The firm currently has a neutral rating on the stock.
Citigroup (NYSE:C) had its price target boosted by The Goldman Sachs Group, Inc. from $123.00 to $137.00. They currently have a buy rating on the stock.
Cogeco Communications (TSE:CCA) had its price target trimmed by Canaccord Genuity Group Inc. from C$76.00 to C$74.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
tse-Gesellschaft für Technologie und Systementwicklung mbH (TSE:DE) had its target price raised by ATB Cormark Capital Markets from C$10.75 to C$11.50. The firm currently has an outperform rating on the stock.
High Liner Foods (TSE:HLF) had its price target cut by ATB Cormark Capital Markets from C$24.00 to C$19.50. The firm currently has a speculative buy rating on the stock.
Ivanhoe Mines (TSE:IVN) had its price target trimmed by Canaccord Genuity Group Inc. from C$15.00 to C$11.50. Canaccord Genuity Group Inc. currently has a hold rating on the stock.
Cannara Biotech (CNSX:LOVE) was given a $3.00 price target by analysts at Haywood Securities. The firm currently has a buy rating on the stock.
Merck & Co., Inc. (NYSE:MRK) had its price target increased by JPMorgan Chase & Co. from $125.00 to $135.00. They currently have an overweight rating on the stock.
MTY Food Group (TSE:MTY) was given a C$49.00 target price by analysts at National Bank Financial. The firm currently has an outperform rating on the stock.
KindlyMD (NASDAQ:NAKA) had its target price reduced by Maxim Group from $1.50 to $0.75. The firm currently has a buy rating on the stock.
Oruka Therapeutics (NASDAQ:ORKA) had its target price increased by UBS Group AG from $50.00 to $75.00. UBS Group AG currently has a buy rating on the stock.
Quarterhill (TSE:QTRH) had its target price increased by ATB Cormark Capital Markets from C$2.00 to C$2.75. They currently have an outperform rating on the stock.
Shopify (TSE:SHOP) had its target price reduced by Wells Fargo & Company from C$191.00 to C$166.00. The firm currently has an overweight rating on the stock.
Troilus Gold (CVE:TLG) was given a C$4.00 price target by analysts at Ventum Financial. The firm currently has a buy rating on the stock.
Receive News & Ratings for Alaris Equity Partners Income Trust (ADUN) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alaris Equity Partners Income Trust (ADUN) and related companies with MarketBeat.com's FREE daily email newsletter.
